| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO, CFO, Director | Chief Financial Officer
1 company
Finley John David is a CEO, CFO, Director at PALISADE BIO, INC.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $25K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 | PALI Palisade Bio, Inc. | Chief Financial Officer | Buy | 10,000 | $2.65 | $26,468.00 | +156.4% | -8.7% | -92.7% |